Willow Bioscience shifts focus to opportunity with BioOxi bio-oxidation platform

About this update from Atlas Energy Corp.

[{"type":"text","content":"Willow Bioscience shifts focus to opportunity with BioOxi bio-oxidation platform\n \n \n (NewsDirect)\n \n \n \n \n Willow Bioscience CEO Dr Chris Savile\njoined Steve Darling from Proactive to share news the company has\nembarked on a major strategic shift, focusing its commercial efforts\non the BioOxi platform. To assist in this transition, Willow\nBiosciences has engaged an advisor to explore and evaluate potential\nopportunities.\n \n \n This move is part of\na broader strategy that also encompasses a collaborative venture with\na Nasdaq-listed biopharmaceutical company. Together, they are working\nto establish sustainable manufacturing routes for key intermediates\nand active pharmaceutical ingredients.\n \n \n Savile highlighted the company's achievements in executing\nsuccessful commercial programs. Notably, four new programs linked to\nthe BioOxi bio-oxidation platform technology were launched in April\n2023.\n \n \n Willow Biosciences is now\nconcentrating on partner-funded enzyme engineering engagements, a\nstrategic shift aimed at enhancing cost efficiency and optimizing the\npathway to revenue growth.\n \n \n This\nrefocusing strategy aligns with the company's commitment to\nunlocking nearer-term and potentially larger revenue opportunities,\nparticularly compared to its legacy strain engineering business.\n \n \n Furthermore, Savile shared insights into\nthe company's operational evolution. Willow Biosciences has\ncompleted a seamless transition, consolidating its operations into a\nsingle, cost-efficient facility located in Sunnyvale, California. This\nfacility not only caters to the present needs of the company but also\naccommodates future growth prospects.\n \n \n With ample laboratory\nspace, Willow Biosciences can continue to expand its collaborative\nefforts while maintaining a financially prudent approach, in contrast\nto previous locations. bolstered by cost-effective operations and a\nfocused commercial approach.\n \n \n \n Contact\nDetails\n \n \n \n Proactive Investors\n \n \n +1 604-688-8158\n \n \n \n [email protected]\n \n \n \n Copyright (c) 2023 TheNewswire - All rights reserved.\n \n \n","length":2655,"tagName":"div"}]

More updates from Atlas Energy Corp.